208 related articles for article (PubMed ID: 24619394)
1. Fluid-attenuated inversion recovery hyperintensity correlates with matrix metalloproteinase-9 level and hemorrhagic transformation in acute ischemic stroke.
Jha R; Battey TW; Pham L; Lorenzano S; Furie KL; Sheth KN; Kimberly WT
Stroke; 2014 Apr; 45(4):1040-5. PubMed ID: 24619394
[TBL] [Abstract][Full Text] [Related]
2. Fluid-attenuated inversion recovery hyperintensity in acute ischemic stroke may not predict hemorrhagic transformation.
Campbell BC; Costello C; Christensen S; Ebinger M; Parsons MW; Desmond PM; Barber PA; Butcher KS; Levi CR; De Silva DA; Lansberg MG; Mlynash M; Olivot JM; Straka M; Bammer R; Albers GW; Donnan GA; Davis SM;
Cerebrovasc Dis; 2011; 32(4):401-5. PubMed ID: 21986096
[TBL] [Abstract][Full Text] [Related]
3. MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type IV collagen degradation during hemorrhagic transformation after human ischemic stroke.
Rosell A; Cuadrado E; Ortega-Aznar A; Hernández-Guillamon M; Lo EH; Montaner J
Stroke; 2008 Apr; 39(4):1121-6. PubMed ID: 18323498
[TBL] [Abstract][Full Text] [Related]
4. Fluid-Attenuated Inversion Recovery Hyperintensity Is Associated with Hemorrhagic Transformation following Reperfusion Therapy.
Ahn SH; Kim BJ; Kim YJ; Kwon SU; Kim JS; Kang DW
J Stroke Cerebrovasc Dis; 2017 Feb; 26(2):327-333. PubMed ID: 27771196
[TBL] [Abstract][Full Text] [Related]
5. The Role of the Signal Intensity Ratio on Fluid-Attenuated Inversion Recovery in Stroke Patients Achieving Successful Recanalization with Endovascular Treatment.
Kim T; Chung JW; Jang MS; Yang MH; Lee SH; Kim BJ; Han MK; Kim JH; Jung C; Lim JS; Bae HJ
J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):1528-1534. PubMed ID: 28342654
[TBL] [Abstract][Full Text] [Related]
6. Sulcal hyperintensity on fluid-attenuated inversion recovery imaging in acute ischemic stroke patients treated with intra-arterial thrombolysis: iodinated contrast media as its possible cause and the association with hemorrhagic transformation.
Kim EY; Kim SS; Na DG; Roh HG; Ryoo JW; Kim HK
J Comput Assist Tomogr; 2005; 29(2):264-9. PubMed ID: 15772550
[TBL] [Abstract][Full Text] [Related]
7. Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke.
Castellanos M; Leira R; Serena J; Pumar JM; Lizasoain I; Castillo J; Dávalos A
Stroke; 2003 Jan; 34(1):40-6. PubMed ID: 12511748
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke.
Montaner J; Alvarez-Sabín J; Molina CA; Anglés A; Abilleira S; Arenillas J; Monasterio J
Stroke; 2001 Dec; 32(12):2762-7. PubMed ID: 11739970
[TBL] [Abstract][Full Text] [Related]
9. Hemorrhagic transformation after ischemic stroke in animals and humans.
Jickling GC; Liu D; Stamova B; Ander BP; Zhan X; Lu A; Sharp FR
J Cereb Blood Flow Metab; 2014 Feb; 34(2):185-99. PubMed ID: 24281743
[TBL] [Abstract][Full Text] [Related]
10. Matrix Metalloproteinase-9 Mediates the Deleterious Effects of α2-Antiplasmin on Blood-Brain Barrier Breakdown and Ischemic Brain Injury in Experimental Stroke.
Singh S; Houng AK; Reed GL
Neuroscience; 2018 Apr; 376():40-47. PubMed ID: 29294343
[TBL] [Abstract][Full Text] [Related]
11. Early infarct FLAIR hyperintensity is associated with increased hemorrhagic transformation after thrombolysis.
Kufner A; Galinovic I; Brunecker P; Cheng B; Thomalla G; Gerloff C; Campbell BC; Nolte CH; Endres M; Fiebach JB; Ebinger M
Eur J Neurol; 2013 Feb; 20(2):281-5. PubMed ID: 22900825
[TBL] [Abstract][Full Text] [Related]
12. Contrast-enhanced MR imaging in acute ischemic stroke: T2* measures of blood-brain barrier permeability and their relationship to T1 estimates and hemorrhagic transformation.
Thornhill RE; Chen S; Rammo W; Mikulis DJ; Kassner A
AJNR Am J Neuroradiol; 2010 Jun; 31(6):1015-22. PubMed ID: 20190209
[TBL] [Abstract][Full Text] [Related]
13. MRI detection of early blood-brain barrier disruption: parenchymal enhancement predicts focal hemorrhagic transformation after thrombolysis.
Hjort N; Wu O; Ashkanian M; Sølling C; Mouridsen K; Christensen S; Gyldensted C; Andersen G; Østergaard L
Stroke; 2008 Mar; 39(3):1025-8. PubMed ID: 18258832
[TBL] [Abstract][Full Text] [Related]
14. Multi-center prediction of hemorrhagic transformation in acute ischemic stroke using permeability imaging features.
Scalzo F; Alger JR; Hu X; Saver JL; Dani KA; Muir KW; Demchuk AM; Coutts SB; Luby M; Warach S; Liebeskind DS;
Magn Reson Imaging; 2013 Jul; 31(6):961-9. PubMed ID: 23587928
[TBL] [Abstract][Full Text] [Related]
15. Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke.
Rosell A; Ortega-Aznar A; Alvarez-Sabín J; Fernández-Cadenas I; Ribó M; Molina CA; Lo EH; Montaner J
Stroke; 2006 Jun; 37(6):1399-406. PubMed ID: 16690896
[TBL] [Abstract][Full Text] [Related]
16. A Therapeutic Target of Cerebral Hemorrhagic Stroke: Matrix Metalloproteinase- 9.
Dang B; Duan X; Wang Z; He W; Chen G
Curr Drug Targets; 2017; 18(12):1358-1366. PubMed ID: 28460607
[TBL] [Abstract][Full Text] [Related]
17. Progesterone attenuates hemorrhagic transformation after delayed tPA treatment in an experimental model of stroke in rats: involvement of the VEGF-MMP pathway.
Won S; Lee JH; Wali B; Stein DG; Sayeed I
J Cereb Blood Flow Metab; 2014 Jan; 34(1):72-80. PubMed ID: 24045404
[TBL] [Abstract][Full Text] [Related]
18. Safety profile of tissue plasminogen activator treatment among stroke patients carrying a common polymorphism (C-1562T) in the promoter region of the matrix metalloproteinase-9 gene.
Montaner J; Fernández-Cadenas I; Molina CA; Monasterio J; Arenillas JF; Ribó M; Quintana M; Chacón P; Andreu AL; Alvarez-Sabín J
Stroke; 2003 Dec; 34(12):2851-5. PubMed ID: 14605329
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke.
Montaner J; Molina CA; Monasterio J; Abilleira S; Arenillas JF; Ribó M; Quintana M; Alvarez-Sabín J
Circulation; 2003 Feb; 107(4):598-603. PubMed ID: 12566373
[TBL] [Abstract][Full Text] [Related]
20. Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia.
Liu W; Hendren J; Qin XJ; Liu KJ
Stroke; 2009 Jul; 40(7):2526-31. PubMed ID: 19478225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
